EPIZYME INC's ticker is EPZM and the CUSIP is 29428V104. A total of 133 filers reported holding EPIZYME INC in Q4 2021. The put-call ratio across all filers is 21.74 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2021 | $266,000 | -43.5% | 51,919 | -8.4% | 0.12% | -39.7% |
Q2 2021 | $471,000 | +12.7% | 56,674 | +18.2% | 0.19% | +9.6% |
Q1 2021 | $418,000 | -17.4% | 47,948 | +2.8% | 0.18% | -15.7% |
Q4 2020 | $506,000 | +25.9% | 46,638 | +38.4% | 0.21% | -0.5% |
Q3 2020 | $402,000 | -18.8% | 33,686 | +9.2% | 0.21% | -9.8% |
Q2 2020 | $495,000 | +57.1% | 30,849 | +51.9% | 0.23% | +80.0% |
Q1 2020 | $315,000 | -44.9% | 20,306 | -12.7% | 0.13% | +38.3% |
Q4 2019 | $572,000 | +155.4% | 23,272 | +7.1% | 0.09% | +108.9% |
Q3 2019 | $224,000 | -22.2% | 21,720 | -5.3% | 0.04% | -26.2% |
Q2 2019 | $288,000 | -48.8% | 22,930 | -49.6% | 0.06% | -94.9% |
Q1 2019 | $563,000 | +79.9% | 45,462 | -10.6% | 1.20% | +2160.4% |
Q4 2018 | $313,000 | -0.9% | 50,838 | +70.3% | 0.05% | +60.6% |
Q3 2018 | $316,000 | -54.5% | 29,855 | -41.7% | 0.03% | -94.6% |
Q2 2018 | $694,000 | -34.1% | 51,203 | -13.7% | 0.61% | -32.8% |
Q1 2018 | $1,053,000 | +204.3% | 59,330 | +115.4% | 0.91% | +110.6% |
Q4 2017 | $346,000 | -32.0% | 27,541 | +3.1% | 0.43% | +529.0% |
Q3 2017 | $509,000 | +39.1% | 26,709 | +10.1% | 0.07% | +25.5% |
Q2 2017 | $366,000 | -15.7% | 24,266 | -4.2% | 0.06% | -28.6% |
Q1 2017 | $434,000 | +56.7% | 25,328 | +10.6% | 0.08% | -7.2% |
Q4 2016 | $277,000 | +29.4% | 22,900 | +5.3% | 0.08% | -19.4% |
Q3 2016 | $214,000 | -4.0% | 21,750 | 0.0% | 0.10% | -37.6% |
Q2 2016 | $223,000 | +12.1% | 21,750 | +32.6% | 0.16% | -39.8% |
Q1 2016 | $199,000 | – | 16,400 | – | 0.27% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
RP Management, LLC | 9,166,667 | $109,358,000 | 16.39% |
Burrage Capital Management LLC | 1,002,528 | $11,960,000 | 9.44% |
Foresite Capital Management III, LLC | 998,278 | $11,909,000 | 8.87% |
MPM BioImpact LLC | 2,854,737 | $34,057,000 | 8.20% |
Palo Alto Investors LP | 6,403,600 | $76,395,000 | 4.19% |
Foresite Capital Management II, LLC | 862,402 | $10,288,000 | 2.24% |
Redmile Group, LLC | 8,311,633 | $99,158,000 | 1.82% |
Pier Capital, LLC | 574,299 | $6,851,000 | 1.00% |
Foresite Capital Management I, LLC | 243,759 | $2,908,000 | 0.82% |
Rock Springs Capital Management LP | 2,551,659 | $30,441,000 | 0.77% |